Filing Details
- Accession Number:
- 0001061983-21-000243
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-10-21 18:47:23
- Reporting Period:
- 2021-10-19
- Accepted Time:
- 2021-10-21 18:47:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1061983 | Cytokinetics Inc | CYTK | Pharmaceutical Preparations (2834) | 943291317 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1710875 | Ching Jaw | 280 East Grand Avenue South San Francisco CA 94080 | Svp Finance & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-10-19 | 35,687 | $35.73 | 53,064 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Amount of securities beneficially owned following reported transaction has been adjusted by 182 shares representing shares purchased pursuant to ESPP but that have not been previously reported.Reporting persons Form 4 filed on March 09, 2021 erroneously stated that the reported 88,492 shares owned following reporting persons transaction on March 08, 2021 included 727 shares of common stock purchased pursuant to ESPP, but in fact only 545 shares of common stock purchased pursuant to ESPP were included in that 88,492 share total.
- Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 15, 2021.
- Includes 804 shares of common stock purchased pursuant to the Issuers 2015 Employee Stock Purchase Plan (ESPP).
Billionaire Hedge Funds
